文献速递慢性肾脏病

水通道蛋白11 rs2276415变异与慢性肾脏病进展

Aquaporin 11 rs2276415 variant and progression of chronic kidney disease.
PubMed 文献 · Nephrol Dial Transplant · 2019-01-01

该前瞻性队列研究纳入中国620例未透析的CKD 2-5期患者,随访3年。结果显示AQP11 rs2276415的A等位基因(GA+AA)使CKD进展风险增加1.92倍(95%CI 1.31-2.84),且呈基因剂量效应(log-rank P<0.001)。

要点

  • AQP11 rs2276415 A等位基因与CKD进展风险独立相关。
  • 风险增加1.92倍(95%CI 1.31-2.84),呈基因剂量效应。
  • 该关联在中国CKD人群中独立于传统危险因素。

核心结论

  • AQP11 rs2276415变异可预测中国人群CKD进展,独立于传统危险因素。

主要发现

  • 随访期间170例发生CKD进展。
  • 无事件生存率显著依赖于AQP11基因型,呈明显基因剂量效应(log-rank P<0.001)。
  • 调整性别、年龄及主要CKD危险因素后,AQP11 A等位基因(GA+AA)使CKD进展风险增加1.92倍(95%CI 1.31-2.84)。

关键数值与推荐

  • CKD进展定义为血肌酐较基线升高至少0.4 mg/dL(35 µmol/L)或开始维持性透析或移植。
  • AQP11 rs2276415 A等位基因(GA+AA)vs 非A等位基因的CKD进展风险比1.92(95%CI 1.31-2.84)。

临床怎么用

  • 在CKD患者中检测AQP11 rs2276415变异可能有助于风险分层。
  • 针对该变异的通路探索可能为CKD治疗提供新靶点。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The Aquaporin 11 (AQP11) rs2276415 variant has been implicated in kidney disease in Type 2 diabetes. Association of the AQP11 variant with chronic kidney disease (CKD) beyond diabetic nephropathy is unknown, with no studies reported in the Chinese population. We explored the risk of CKD progression associated with the AQP11 rs2276415 variant in a population-based study in China. METHODS: We conducted a prospective cohort study of 620 participants with CKD (Stages 2-5 and who were not receiving dialysis) at the Nephrology Center of First Affiliated Hospital of Jiaxing University between July 2011 and December 2014 and followed up for 3 years. Incident CKD progression, defined as an increase in creatinine levels of at least 0.4 mg/dL (35 µmol/L) above baseline or maintenance dialysis initiation or transplantation, was examined by AQP11 genotypes. RESULTS: During the follow-up period, CKD progression developed in 170 individuals. Cumulative events-free survival was significantly dependent on AQP11 genotypes with an apparent gene-dose effect (log-rank P < 0.001). Adjusting for sex, age and major CKD risk factors, the A allele of AQP11 gene (GA + AA) increased the risk of CKD progression by 1.92 (95% confidence interval 1.31- 2.84). CONCLUSIONS: The AQP11 rs2276415 variant predicts CKD progression in the Chinese population, independent of traditional risk factors. Exploring the pathways mediating the association may shed light on novel therapeutic targets in the pathophysiology of CKD.

来源:Nephrol Dial Transplant,查看原文。版权归原作者所有。

引用

  1. Han B, Wu X, Huang PP, et al. Aquaporin 11 rs2276415 variant and progression of chronic kidney disease. Nephrol Dial Transplant. 2019. PMID: 30010847. doi:10.1093/ndt/gfy219

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。